Point mutation of the autophosphorylation site or in the nuclear location signal causes protein kinase A RII beta regulatory subunit to lose its ability to revert transformed fibroblasts.
- 7 November 1995
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 92 (23) , 10634-10638
- https://doi.org/10.1073/pnas.92.23.10634
Abstract
The RII beta regulatory subunit of cAMP-dependent protein kinase (PKA) contains an autophosphorylation site and a nuclear location signal, KKRK. We approached the structure-function analysis of RII beta by using site-directed mutagenesis. Ser114 (the autophosphorylation site) of human RII beta was replaced with Ala (RII beta-P) or Arg264 of KKRK was replaced with Met (RII beta-K). ras-transformed NIH 3T3 (DT) cells were transfected with expression vectors for RII beta, RII beta-P, and RII beta-K, and the effects on PKA isozyme distribution and transformation properties were analyzed. DT cells contained PKA-I and PKA-II isozymes in a 1:2 ratio. Over-expression of wild-type or mutant RII beta resulted in an increase in PKA-II and the elimination of PKA-I. Only wild-type RII beta cells demonstrated inhibition of both anchorage-dependent and -independent growth and phenotypic change. The growth inhibitory effect of RII beta overexpression was not due to suppression of ras expression but was correlated with nuclear accumulation of RII beta. DT cells demonstrated growth inhibition and phenotypic change upon treatment with 8-Cl-cAMP. RII beta-P or RII beta-K cells failed to respond to 8-Cl-cAMP. These data suggest that autophosphorylation and nuclear location signal sequences are integral parts of the growth regulatory mechanism of RII beta.Keywords
This publication has 45 references indexed in Scilit:
- A single-injection protein kinase A-directed antisense treatment to inhibit tumour growthNature Medicine, 1995
- Selective modulation of protein kinase isozymes by the site-selective analog 8-chloroadenosine 3',5'-cyclic monophosphate provides a biological means for control of human colon cancer cell growth.Proceedings of the National Academy of Sciences, 1988
- Site‐selective cyclic AMP analogs provide a new approach in the control of cancer cell growthFEBS Letters, 1987
- Sarcoma viruses carrying ras oncogenes induce differentiation-associated properties in a neuronal cell lineNature, 1985
- A short amino acid sequence able to specify nuclear locationCell, 1984
- Amino acid sequence of the regulatory subunit of bovine type II cAMP-dependent protein kinaseBiochemistry, 1984
- Cyclic AMP‐dependent protein kinases from Balb 3T3 cells and other 3T3 derived linesJournal of Cellular Physiology, 1981
- Phosphorylation-Dephosphorylation of EnzymesAnnual Review of Biochemistry, 1979
- Cyclic AMP-dependent protein kinases from normal and SV40-transformed 3T3 cellsNature, 1976
- Isolation of pure and unaltered liver nuclei morphology and biochemical compositionExperimental Cell Research, 1956